1 results match your criteria: "Paris Est Créteil University dGroupe Hospitalier Henri-Mondor Albert-Chenevier[Affiliation]"
Serum suppression of tumorigenicity 2 level is an independent predictor of all-cause mortality in HIV-infected patients.
AIDS
November 2017
aBordeaux University, INSERM U1219, Bordeaux Population Health Research Center, INRIA Sistm bCentre Hospitalier Universitaire de Bordeaux, Bordeaux cINSERM U955, Paris Est Créteil University dGroupe Hospitalier Henri-Mondor Albert-Chenevier, Créteil, France. *Rodolphe Thiébaut and Sophie Hue cocontributing authors.
Objective: To evaluate the predictive value of soluble suppression of tumorigenicity 2 (sST2), a decoy receptor of IL-33 involved in several inflammatory and immune diseases, for death in HIV infection.
Design: Patients enrolled in the ANRS CO3 Aquitaine Cohort, a prospective hospital-based cohort of HIV-1-infected patients, who had a plasma sample available in the biobank were systematically eligible.
Methods: sST2, soluble CD14 (sCD14) and IL-6 were measured using Luminex multiplex bead-based technology (R&D Systems) and a Bio-Plex 200 instrument (BioRad).